BOSTON--(BUSINESS WIRE)--Amwell®, (NYSE: AMWL) a national telehealth leader, today announced the continued expansion of its platform with the release of the Hospital TV 100. Designed to further expand integrated telehealth connectivity via the Amwell platform, the new Carepoint™ device enables hospitals to turn existing televisions into telehealth endpoints, allowing them to scale and simplify access to their telehealth infrastructure by using devices that already exist in patient rooms.
“We believe telehealth has a powerful role to play in the democratization of healthcare, and in working towards this goal, we are building out our platform to enable the convergence of healthcare experiences across care settings, making it easier for those on the frontlines to see their patients,” said Ido Schoenberg, co-CEO and Chairman, Amwell. “This new Carepoint device demonstrates our mission to connect and enable the key players across the healthcare ecosystem to improve clinical and financial outcomes. Streamlined, integrated connectivity between patients and informed, trusted providers is central to realizing this goal.”
The Hospital TV 100 brings providers directly into a hospital room. As health systems grapple with strained resources and the COVID-19 pandemic, the new Carepoint device helps providers to safely monitor patients, while hospitals can use their existing in-room TV investments to scale telemedicine across their entire system. Patients also benefit from connecting with entire care teams across a wide range of specialties, without needing to leave their room or have a care team member present to facilitate.
“Being able to turn our existing televisions into telehealth devices has made it easier for our care teams to see their patients,” said Brian Wayling, Assistant Vice President of Telehealth Services, Intermountain Healthcare. “At Intermountain, we now have over 1,200 Amwell TV Carepoint devices installed in almost 50 locations. The in-room smart TV and networking enable clinical teams across more than 30 specialties to provide remote care 24/7 in collaboration with the local team, and to interact with patients, family members, and caregivers right in the patient’s room—no matter the access concerns and without any extra effort.”
“Intermountain is a world class digital health leader. We are inspired by their and other providers heroic and courageous work. It is a privilege to bring to market a solution that makes it safer and easier for them to deliver care,” continued Schoenberg.
The Hospital TV 100 is available now, from Amwell. For more information visit: https://business.amwell.com/telemedicine-equipment/hospital-tv-kit/
About Amwell
Amwell is a leading telehealth platform in the United States and globally, connecting and enabling providers, insurers, patients, and innovators to deliver greater access to more affordable, higher quality care. Amwell believes that digital care delivery will transform healthcare. The Company offers a single, comprehensive platform to support all telehealth needs from urgent to acute and post-acute care, as well as chronic care management and healthy living. With over a decade of experience, Amwell powers telehealth solutions for over 2,000 hospitals and 55 health plan partners with over 36,000 employers, covering over 80 million lives. For more information, please visit https://business.amwell.com/.
American Well, Amwell and Carepoint are registered trademarks or trademarks of American Well Corporation in the United States and other countries. All other trademarks used herein are the property of their respective owners.
Forward-Looking Statements
This press release contains forward-looking statements about us and our industry that involve substantial risks and uncertainties and are based on our beliefs and assumptions and on information currently available to us. All statements other than statements of historical facts contained in this press release, including statements regarding our future results of operations, financial condition, business strategy and plans and objectives of management for future operations, are forward-looking statements. In some cases, you can identify forward-looking statements because they contain words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “will,” or “would,” or the negative of these words or other similar terms or expressions.
Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance, or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Forward-looking statements represent our beliefs and assumptions only as of the date of this release. These statements, and related risks, uncertainties, factors and assumptions, include, but are not limited to: weak growth and increased volatility in the telehealth market; inability to adapt to rapid technological changes; increased competition from existing and potential new participants in the healthcare industry; changes in healthcare laws, regulations or trends and our ability to operate in the heavily regulated healthcare industry; our ability to comply with federal and state privacy regulations; the significant liability that could result from a cybersecurity breach; and other factors described under ‘Risk Factors’ in the prospectus for our IPO filed with the SEC. These risks are not exhaustive. Except as required by law, we assume no obligation to update these forward-looking statements, or to update the reasons actual results could differ materially from those anticipated in the forward-looking statements, even if new information becomes available in the future. Further information on factors that could cause actual results to differ materially from the results anticipated by our forward-looking statements is included in the reports we have filed or will file with the Securities and Exchange Commission. These filings, when available, are available on the investor relations section of our website at investors.amwell.com and on the SEC’s website at www.sec.gov.
